Portnoy Law Firm Announces Class Action on Behalf of Cytokinetics, Inc. Investors - Cytokinetics ( NASDAQ:CYTK )
LOS ANGELES, Oct. 03, 2025 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Cytokinetics, Inc., ( "Cytokinetics" or the "Company" ) ( NASDAQ:CYTK ) investors of a class action on behalf of investors that bought securities between December 27, 2023 and May 6, 2025, inclusive ( the "Class ...
DEADLINE ALERT for CYTK, NX, JSPR, and KBR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Cytokinetics ( NASDAQ:CYTK ) , Jasper Therapeutics ( NASDAQ:JSPR )
LOS ANGELES, Oct. 03, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Deadline Alert: Cytokinetics, Incorporated ( CYTK ) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - Cytokinetics ( NASDAQ:CYTK )
LOS ANGELES, Oct. 02, 2025 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 17, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Cytokinetics, Incorporated ( ...
Can CYTK Clinch a Potential FDA Nod for Its Cardiovascular Drug?
Cytokinetics' aficamten shows superiority over metoprolol in late-stage oHCM trial, boosting investor confidence despite FDA delay.
NATIONALLY RANKED ROSEN LAW FIRM Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Oct. 01, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. ( NASDAQ:CYTK ) between December 27, 2023 and May 6, 2025, both dates inclusive ( the "Class Period" ) , of the important November 17, ...
Cal-Maine Foods Posts Downbeat Earnings, Joins Enanta Pharmaceuticals, AAR And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Cal-Maine Foods ( NASDAQ:CALM ) , AAR ( NYSE:AIR )
U.S. stock futures were lower this morning, with the Dow futures falling more than 200 points on Wednesday. Shares of Cal-Maine Foods Inc ( NASDAQ:CALM ) fell sharply in pre-market trading after the company posted weaker-than-expected first-quarter results.
CYTOKINETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK CITY and NEW ORLEANS, Sept. 30, 2025 ( GLOBE NEWSWIRE ) -- Kahn Swick & Foti, LLC ( "KSF" ) and KSF partner, former Attorney General of Louisiana, Charles C.
Bragar Eagel & Squire, P.C. Reminds Investors of VFC, Cytokinetics, Quanex, and RCI that Class Action Lawsuits Have Been Filed and Encourages Investors to Contact the Firm - Cytokinetics ( NASDAQ:CYTK ) , Quanex Building Prods ( NYSE:NX )
NEW YORK, Sept. 30, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of V.F.
DEADLINE ALERT for LNTH, VFC, FLR, CYTK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - Cytokinetics ( NASDAQ:CYTK ) , Fluor ( NYSE:FLR )
BENSALEM, Pa., Sept. 30, 2025 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics - Cytokinetics ( NASDAQ:CYTK )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options
Shareholders who lost money in shares of Cytokinetics, Incorporated ( NASDAQ: CYTK ) Should Contact Wolf Haldenstein Immediately Lead Plaintiff Deadline is November 17, 2025 - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Sept. 29, 2025 ( GLOBE NEWSWIRE ) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all individuals and entities who purchased or otherwise ...
Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025 - Cytokinetics ( NASDAQ:CYTK )
Additional Data from MAPLE-HCM Show Aficamten Significantly Improves Measures of Maximal and Submaximal Exercise Capacity and Recovery Compared to Metoprolol 96-Week Analyses from FOREST-HCM Support Long-Term Efficacy and Tolerability of Aficamten in Patients with Non-Obstructive HCM
Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025
Additional Data from MAPLE-HCM Show Aficamten Significantly Improves Measures of Maximaland Submaximal Exercise Capacity and Recovery Compared to ...
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Sept. 28, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Cytokinetics, Inc. ( NASDAQ: CYTK ) between December 27, 2023 and May 6, 2025, both dates inclusive ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CYTK
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action ...
DEADLINE ALERT for CYTK, NX, JSPR, and KBR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Cytokinetics ( NASDAQ:CYTK ) , Jasper Therapeutics ( NASDAQ:JSPR )
LOS ANGELES, Sept. 26, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Sept. 25, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Cytokinetics, Inc. ( NASDAQ: CYTK ) between December 27, 2023 and May 6, 2025, both dates inclusive ...
Cytokinetics, Incorporated Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Sept. 25, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ( "Cytokinetics" or the "Company" ) ( NASDAQ: CYTK ) of a class action securities lawsuit.
CYTOKINETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW ORLEANS, Sept. 25, 2025 ( GLOBE NEWSWIRE ) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokinetics, Incorporated ( NASDAQ: CYTK ) , if they ...
Bragar Eagel & Squire, P.C. Reminds Investors of VFC, Cytokinetics, Quanex, and RCI that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm - Cytokinetics ( NASDAQ:CYTK ) , Quanex Building Prods ( NYSE:NX )
NEW YORK, Sept. 24, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of V.F.
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. ( NASDAQ: CYTK ) ; Fluor Corporation ( NYSE: FLR ) ; and Fly-E Group, Inc. ( NASDAQ: FLYE ) ; and RCI Hospitality Holdings, Inc. ( NASDAQ: RICK ) : Grabar Law Office is Investigating Claims on Your Behalf - Cytokinetics ( NASDAQ:CYTK ) , Fluor ( NYSE:FLR )
PHILADELPHIA, Sept. 24, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. CYTK. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program - Cytokinetics ( NASDAQ:CYTK )
Program to Provide Support of Communications and Outreach for Patient Advocacy Organizations Focused on Cardiovascular Diseases Deadline for Applications is November 3rd, 2025
Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program
Program to Provide Support of Communications and Outreach for Patient Advocacy Organizations Focused on Cardiovascular Diseases ...
Cytokinetics to Present at the Stifel 2025 Virtual Cardiometabolic Forum - Cytokinetics ( NASDAQ:CYTK )
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2025 ( GLOBE NEWSWIRE ) -- Cytokinetics, Incorporated CYTK today announced that members of the Company's management team are scheduled to present a corporate update at the Stifel 2025 Virtual Cardiometabolic Forum on Tuesday, September 30, 2025 at 10:00 AM ...
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. ( NASDAQ: CYTK ) ; Elevance Health Inc. ( NYSE: ELV ) ; Fluor Corporation ( NYSE: FLR ) ; and Fly-E Group, Inc. ( NASDAQ: FLYE ) : Grabar Law Office is Investigating Claims on Your Behalf - Cytokinetics ( NASDAQ:CYTK ) , Elevance Health ( NYSE:ELV )
PHILADELPHIA, Sept. 23, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. CYTK. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
CYTOKINETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK CITY and NEW ORLEANS, Sept. 22, 2025 ( GLOBE NEWSWIRE ) -- Kahn Swick & Foti, LLC ( "KSF" ) and KSF partner, former Attorney General of Louisiana, Charles C.
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ...
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Sept. 19, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ( "Cytokinetics" or the "Company" ) CYTK of a class action securities lawsuit.
CYTK Investor Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Cytokinetics, Inc. - Cytokinetics ( NASDAQ:CYTK )
SAN DIEGO, Sept. 19, 2025 ( GLOBE NEWSWIRE ) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Cytokinetics, Inc. CYTK securities between December 27, 2023 and May 6, 2025.
DEADLINE ALERT for LNTH and CYTK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Cytokinetics ( NASDAQ:CYTK ) , Lantheus Holdings ( NASDAQ:LNTH )
LOS ANGELES, Sept. 19, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
CYTOKINETICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cytokinetics, Incorporated and Encourages Investors to Contact the Firm - Cytokinetics ( NASDAQ:CYTK )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Cytokinetics ( CYTK ) To Contact Him Directly To Discuss Their Options
Cytokinetics, Inc. Investigated by the Portnoy Lawfirm - Cytokinetics ( NASDAQ:CYTK )
LOS ANGELES, Sept. 18, 2025 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Cytokinetics, Inc., ( "Cytokinetics" or the "Company" ) CYTK investors of a class action on behalf of investors that bought securities between December 27, 2023 and May 6, 2025, inclusive ( the "Class Period" ) .
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( C ) ( 4 ) - Cytokinetics ( NASDAQ:CYTK )
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 ( GLOBE NEWSWIRE ) -- Cytokinetics, Incorporated CYTK today announced that on September 15, 2025 it granted stock options to purchase an aggregate of 39,790 shares of common stock and 26,822 restricted stock units ( RSUs ) that will be settled in ...
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics - Cytokinetics ( NASDAQ:CYTK )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Cytokinetics To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Cytokinetics ( CYTK ) Investors - Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Cytokinetics ( NASDAQ:CYTK )
ATLANTA, Sept. 18, 2025 ( GLOBE NEWSWIRE ) -- A shareholder class action lawsuit has been filed against Cytokinetics, Incorporated ( "Cytokinetics" or the "Company" ) CYTK. The lawsuit alleges Defendants represented that Cytokinetics expected approval from the U.S.
Cytokinetics Announces Three Upcoming Presentations at the HFSA Annual Scientific Meeting 2025
Long-Term Data from FOREST-HCM in Non-Obstructive HCM and Results from Prespecified Analysis of MAPLE-HCM to be Presented in Late-Breaking Clinical Research Session ...
Cytokinetics Announces Three Upcoming Presentations at the HFSA Annual Scientific Meeting 2025 - Cytokinetics ( NASDAQ:CYTK )
Long-Term Data from FOREST-HCM in Non-Obstructive HCM and Results from Prespecified Analysis of MAPLE-HCM to be Presented in Late-Breaking Clinical Research Session
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Cytokinetics, Incorporated Common Stock and Sets a Lead Plaintiff Deadline of November 17, 2025 - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Sept. 17, 2025 ( GLOBE NEWSWIRE ) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired common stock of Cytokinetics, Incorporated ( "Cytokinetics" or the "Company" ) CYTK between December 27, 2023, to ...
Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update
REDWOOD CITY, Calif., Sept. 17, 2025 ( GLOBE NEWSWIRE ) -- Rezolute, Inc. ( Nasdaq: RZLT ) ( "Rezolute" or the "Company" ) , a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today reported financial results and provided a business update for the ...
Cytokinetics Announces Pricing of Upsized $650.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2027 Convertible Notes - Cytokinetics ( NASDAQ:CYTK )
SOUTH SAN FRANCISCO, Calif., Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Cytokinetics, Incorporated ( "Cytokinetics" ) CYTK today announced the pricing of its offering of $650.0 million aggregate principal amount of 1.75% convertible senior notes due 2031 in a private placement ( the "offering" ) to ...
Cytokinetics Announces Pricing of Upsized $650.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2027 Convertible Notes
SOUTH SAN FRANCISCO, Calif., Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Cytokinetics, Incorporated ( "Cytokinetics" ) ( Nasdaq: CYTK ) today announced the pricing of its offering of $650.0 million aggregate principal amount of 1.75% convertible senior notes due 2031 in a private placement ( the ...
Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes - Cytokinetics ( NASDAQ:CYTK )
SOUTH SAN FRANCISCO, Calif., Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Cytokinetics, Incorporated ( "Cytokinetics" ) CYTK today announced its intention to offer, subject to market conditions and other factors, $550.0 million aggregate principal amount of convertible senior notes due 2031 ( the ...
Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes
SOUTH SAN FRANCISCO, Calif., Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Cytokinetics, Incorporated ( "Cytokinetics" ) ( Nasdaq: CYTK ) today announced its intention to offer, subject to market conditions and other factors, $550.0 million aggregate principal amount of convertible senior notes due 2031 ...
Cytokinetics Gains on Positive Late-Stage Cardiomyopathy Study Results
CYTK shares soar 40% after phase III MAPLE-HCM results showed that aficamten outperformed metoprolol in obstructive HCM.
Company News for Sep 3, 2025
Companies In The News Are: SIG, PEP, CYTK, AL.
Dow Tumbles Over 1%; Nio Shares Edge Lower After Q2 Results - Celularity ( NASDAQ:CELU ) , CARISMA Therapeutics ( NASDAQ:CARM )
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 1% on Tuesday. The Dow traded down 1.08% to 45,052.65 while the NASDAQ fell 1.60% to 21,111.52. The S&P 500 also fell, dropping, 1.32% to 6,374.93. Consumer staples shares jumped by 0.1% on Tuesday.
Cytokinetics ( CYTK ) Stock Is Skyrocketing Tuesday: What's Driving The Action? - Cytokinetics ( NASDAQ:CYTK )
Shares of Cytokinetics are trading sharply higher Tuesday. The company presented new long-term safety and efficacy data for its investigational drug, aficamten. Get Discounted Real-Time Trade Alerts For a Volatile Market ( Labor Day Special ) Shares of Cytokinetics, Inc.
Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday - Apollo Asset Management ( NYSE:APO ) , Air Lease ( NYSE:AL )
U.S. stocks were lower, with the Dow Jones index falling over 250 points on Tuesday. Shares of Air Lease Corporation AL rose sharply during Tuesday's session after the aircraft lessor said it will be acquired by a newly formed Dublin-based holding company backed by Sumitomo Corp.
Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket - ALT5 Sigma ( NASDAQ:ALTS ) , CARISMA Therapeutics ( NASDAQ:CARM )
Shares of Carisma Therapeutics, Inc. CARM rose sharply in pre-market trading after the company announced it will receive a $5 million investment from Ocugen as part of a merger with Ocugen's subsidiary OrthoCelix. Carisma Therapeutics shares jumped 133.4% to $0.5019 in the pre-market trading ...
Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025 - Cytokinetics ( NASDAQ:CYTK )
Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American College of Cardiology
